Cargando…

The placebo effect in allergen-specific immunotherapy trials

BACKGROUND: Double-blind, placebo-controlled (DBPC) trials are the gold standard for demonstrating clinical efficacy and tolerability. The placebo effect, although an important feature in placebo-controlled studies, has never been systematically investigated in allergen-specific immunotherapy (SIT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narkus, Annemie, Lehnigk, Ulrike, Haefner, Dietrich, Klinger, Regine, Pfaar, Oliver, Worm, Margitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878370/ https://www.ncbi.nlm.nih.gov/pubmed/24360060 http://dx.doi.org/10.1186/2045-7022-3-42

Ejemplares similares

Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis
por: Worm, Margitta, et al.
Publicado: (2023)

Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studies
por: Häfner, Dietrich, et al.
Publicado: (2014)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018)

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023)

Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control
por: Wagenmann, Martin, et al.
Publicado: (2019)

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022)

Can open label placebos improve pain and gluten tolerance via open label placebos in fibromyalgia patients? A study protocol for a randomised clinical trial in an outpatient centre
por: Paschke, Lena, et al.
Publicado: (2023)

Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
por: Pfaar, Oliver, et al.
Publicado: (2015)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)

Digital health for allergen immunotherapy
por: Dramburg, Stephanie, et al.
Publicado: (2022)

Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023)

Adherence in allergen immunotherapy: Current situation and future implications
por: Gehrt, Francesca, et al.
Publicado: (2022)

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016)

Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials
por: Abramowicz, Michał, et al.
Publicado: (2018)

Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021)

Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
por: Pfaar, Oliver, et al.
Publicado: (2015)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2018)

Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
por: Pfaar, Oliver, et al.
Publicado: (2023)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2020)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
por: Sager, Angelika, et al.
Publicado: (2012)

AIT und Covid-19 - Empfehlung von DGAKI und AeDA
por: Worm, Margitta, et al.
Publicado: (2020)

An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology
por: Calderón, Moises A, et al.
Publicado: (2014)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
por: Nurmatov, Ulugbek, et al.
Publicado: (2017)

Mechanisms of allergen-specific immunotherapy
por: Fujita, Hiroyuki, et al.
Publicado: (2012)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
por: Akdis, Cezmi A, et al.
Publicado: (2015)

111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases
por: Gutermuth, Jan, et al.
Publicado: (2022)

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
por: Calderon, Moises A, et al.
Publicado: (2012)

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
por: Park, Hye Jung, et al.
Publicado: (2021)

Pepino mosaic virus Infection of Tomato Affects Allergen Expression, but Not the Allergenic Potential of Fruits
por: Welter, Saskia, et al.
Publicado: (2013)

Allergen-Specific Immunotherapy in Food Anaphylaxis
por: Kerzl, Regina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ohlqsbfpr5bflsgi3p9qk2l20f